Correlates of Behavioral Disturbances and Pattern of Psychotropic Medication Use in Five Skilled Nursing Facilities

Journal of Geriatric Psychiatry and Neurology

Volumn 16, Issue 1, 2003, Pages 8-14

  Ramadan, Fadi H ^a,b   Naughton, Bruce J ^a   Prior, Roger ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VALPROIC ACID;

AGED; AGGRESSION; ARTICLE; BATH; BEHAVIOR DISORDER; CHI SQUARE TEST; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLUSTER ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DEMENTIA; DEMOGRAPHY; DRUG CHOICE; DRUG EFFICACY; DRUG UTILIZATION; FEEDING BEHAVIOR; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NURSING HOME; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; SAMPLE; SCORING SYSTEM; TECHNIQUE; AGING; BEHAVIOR; CROSS-SECTIONAL STUDY; PSYCHOLOGICAL ASPECT;

AGED; AGING; BEHAVIORAL SYMPTOMS; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS; SKILLED NURSING FACILITIES;

EID: 0038006963     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/0891988703252177     Document Type: Article

References (63)

1. National Center for Health Statistics. The National Nursing Home Survey: 1985 summary for the United States. DDHS Publication No. PHS 89-1758. Washington, DC: U.S. Government Printing Office, 1989.
2. Zubenko GS, Rosen J, Sweet RA, et al. Impact of psychiatric hospitalization on behavioral complications of Alzheimer's disease. Am J Psychiatry 1992; 149:1484-1491.
3. Kunik ME, Yudofsky SE, Silver JM, et al. Pharmacologic approach to management of agitation associated with dementia. J Clin Psychiatry 1994; 55: (Suppl)13-17.
4. Tariot PN. Treatment of agitation in dementia. J Clin Psychiatry 1999; 60:11-20.
5. Lantz MS, Marin D. Pharmacologic treatment of agitation in dementia: a comprehensive review. J Geriatr Psychiatry Neurol 1996; 9:107-119.
6. Teri L, Logsdon RG. Assessment and management of behavioral disturbances in Alzheimer disease. Compr Ther 2000; 26:169-175.
7. Allen-Burge R, Stevens AB, Burgio LD. Effective behavioral interventions for decreasing dementia-related challenging behavior in nursing homes. Int J Geriatr Psychiatry 1999; 14:213-232.
8. Carlson DL, Fleming KC, Smith GE, et al. Management of dementia-related behavioral disturbances: a non-pharmacologic approach. Mayo Clin Proc 1995; 70:1108-1155.
9. Sultzer D, Gray K, Gunay I. A double blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 1997; 5:60-69.
10. Sultzer DL, Gray KF, Gunay I, et al. Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia? J Am Geriatr Soc 2001; 49:1294-1300.
11. Rojas-Fernandez CH, Lanctot KL, Allen DD, et al. Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm? Pharmacotherapy 2001; 21:74-102.
12. Khachaturian Z. Future research directions. Int Psychogeriatr 1996; 8(Suppl 3):493-495.
13. Lebowitz B. Consensus conference goals and objectives. Int Psychogeriatr 1996; 8(Suppl 3):217-218.
14. Neistein S, Siegal A. Agitation, wandering, pacing, restlessness, and repetitive mannerisms. Int Psychogeriatr 1996; 8(Suppl 3):399-402.
15. Finkel S, Costa e Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8(Suppl 3):497-500.
16. Davis L, Buckwalter K, Burgio L. Measuring problem behaviors in dementia: developing a methodological agenda. Adv Nurs Sci 1997; 20:40-55.
17. Maixner SM, Mellow AA, Tandon R. The efficacy, safety and tolerability of antipsychotics in the elderly. J Clin Psychiatry 1999; 60(Suppl 8):29-41.
18. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563.
19. Lantz MS, Marin D. Pharmacologic treatment of agitation in dementia: a comprehensive review. J Geriatr Psychiatry Neurol 1996; 9:107-119.
20. Stoppe G, Brandt CA, Staedt JH. Behavioral problems associated with dementia. Drugs Aging 1999; 14:41-54.
21. Narayan M, Nelson JC. Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic. J Clin Psychiatry 1997; 58:351-354.
22. Cohen-Mansfield J, Lipson S, Werner P, et al. Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home. Arch Intern Med 1999; 159:1733-1740.
23. Devanand DP, Marder K, Michaels KS, et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 1998; 155:1512-1520.
24. Burke WJ, Dewan V, Wengel SP, et al. The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia. Int J Geriatr Psychiatry 1997; 12:519-525.
25. Pollock BG, Mulsant BH, Sweet R, et al. An open pilot study of citalopram for behavioral disturbances of dementia. Am J Geriatr Psychiatry 1997; 5:70-78.
26. Pollock BG, Rosen J, Mulsant BH, et al. Placebo-controlled comparison of citalopram versus perphenazine for acute treatment of severe behavioral disturbances associated with dementia. Presented at the Annual Meeting of the American Association for Geriatric Psychiatry, 2001; Sanfrancisco, California.
27. Kunik ME, Puryear L, Orengo CA, et al. The efficacy and tolerability of divalproex sodium in the elderly demented patients with behavioral disturbances. Int J Geriatr Psychiatry 1998; 13:29-34.
28. Porsteinsson AP, Tariot PN, Erb R, et al. An open trial of valproate for agitation in geriatric neuropsychiatric disorders. Am J Geriatr Psychiatry 1997; 5:344-351.
29. Mintzer JE, Hoernig KS, Mirski DF. Treatment of agitation in patients with dementia. Clin Geriatr Med 1998; 14:147-175.
30. Christensen DB, Benfield WR. Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients. J Am Geriatr Soc 1998; 46:620-625.
31. Rockwell E, Jackson E, Vilke G, et al. A study of delusions in a large cohort of Alzheimer's disease patients. Am J Geriatr Psychiatry 1994; 2:157-164.
32. Aarsland D, Cummings JL, Yenner G, et al. Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease. Am J Psychiatry 1998; 6:104-121.
33. Gilley DW, Wilson RS, Beckett LA, et al. Psychotic symptoms and physically aggressive behavior in Alzheimer's disease. J Am Geriatr Soc 1997; 45:1074-1079.
34. Katz I, Jetse DV, Mintzer JE, et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 1999; 60:107-115.
35. Chandler JD, Chandler JE. The prevalence of neuropsychiatric disorders in a nursing home population. J Geriatr Psychiatry Neurol 1988; 1:71-76.
36. Mega MS, Cummings JL, Fiorello T, et al. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46:130-135.
37. Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging. Am J Psychiatry 2000; 157:708-714.
38. Ramadan FH, Naughton BJ. Prospective measurement of behavioral disturbances in nursing homes. J Am Med Dir Assoc 2000; 1:149-153.
39. Cohen-Mansfield J. Conceptualization of agitation: results based on the Cohen-Mansfield agitation inventory and the agitation behavior mapping instrument. Int Psychogeriatr 1996; 8(Suppl 3):309-315.
40. Gordon S, Hope T, Burns A. Manchester and Oxford Universities Scale for the Psychopathological Assessment of Dementia (MOUSEPAD). Br J Psychiatry 1996; 169:293-307.
41. Finkel S, Lyons JS, Anderson RL. A brief agitation rating scale (BARS) for nursing home elderly. JAm Geriatr Soc 1993; 41:50-52.
42. Shah A, Heather E, Parkash N. Evaluation of three aggression/agitation behavior rating scales for use on an acute admission and assessment psychogeriatric ward. Int J Geriatr Psychiatry 1998; 13:415-420.
43. Ramadan FH, Naughton BJ. Paroxetine for verbal agitation. Ann Long Term Care 1999; 7:282-286.
44. Katz S, Downs TD, Cash HR, et al. Progress in development of the index of ADL. Gerontologist 1970; 10:20-30.
45. Cohen-Mansfield J. Agitated behaviors in the elderly. Part II. Preliminary results in the cognitively deteriorated. J Am Geriatr Soc 1986; 34:722-727.
46. Cohen-Mansfield J, Werner P. Longitudinal predictors of nonaggressive agitated behaviors in the elderly. Int J Geriatr Psychiatry 1999; 14:831-844.
47. Ryan DP, Tainsh SM, Kolodny V, et al. Noise-making amongst the elderly in long-term care. Gerontologist 1988; 28:369-371.
48. Cariaga J, Burgio L, Flynn W, Martin D. A controlled study of disruptive vocalizations among geriatric residents in nursing homes. J Am Geriatr Soc 1991; 39:501-507.
49. Cohen-Mansfield J, Werner P, Marx MS. Screaming in nursing home residents. J Am Geriatr Soc 1990; 38:785-792.
50. Cohen-Mansfield J. Measurement of inappropriate behavior associated with dementia. J Gerontol Nurs 1999; 25:42-51.
51. Beck C, Rossby L, Baldwin B. Correlates of disruptive behavior in cognitively impaired elderly nursing home residents. Arch Psychiatr Nurs 1991; 5:281-291.
52. Beck C, Frank L, Chumbler NR, et al. Correlates of disruptive behavior in severely cognitively impaired nursing home residents. Gerontologist 1998; 38:189-198.
53. Cohen-Mansfield J, Marx MS, Werner P. Observational data on time use and behavioral problems in nursing home. J Appl Gerontol 1992; 11:111-121.
54. Allen-Burge R, Stevens AB, Burgio LD. Effective behavioral interventions for decreasing dementia-related challenging behavior in nursing homes. Int J Geriatr Psychiatry 1999; 14:213-232.
55. Dietch JT, Jennings RK. Aggressive dyscontrol in patients with benzodiazepines. J Clin Psychiatry 1988; 49:184-188.
56. Lechin F, Van der Dijs B, Benaim M. Benzodiazepines: tolerability in elderly patients. Psychother Psychosom 1996; 65:171-182.
57. Verma S, Daiello LA, Hurley DJ. Managing behavioral disturbances in geriatric population. Ann Long Term Care 2001; 9(Suppl):1-4.
58. Alexopoulos GS, Silver JM, Kahn DA, et al. Treatment of agitation in older persons with dementia. A special report. [Special Issue] Postgrad Med 1998; April: 1-88.
59. Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: incidence, prevention and management. Drug Saf 1999; 21:101-122.
60. Jacobson S, Schreibman B. Behavioral and pharmacologic treatment of delirium. Am Fam Physician 1997; 56:2005-2012.
61. Street JS, Clark S, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing facilities. Arch Gen Psychiatry 2000; 52:968-976.
62. Teri L, Logsdon RG, Peskind E, et al. Treatment of agitation in AD. A randomized, placebo-controlled clinical trial. Neurology 2000; 55:1271-1278.
63. Risse SC, Cubberly L, Lampe TH, et al. Acute effects of neuroleptic withdrawal in elderly demented patients. J Geriatr Drug Ther 1989; 2:65-77.